Expression Therapeutics, Inc., a clinical-stage gene and cell therapy company, today announced that NCI SBIR within the National Institutes of Health (NIH) has awarded a Phase II grant of $2,058,885 ...
When genes are "expressed," it is like reading an instruction manual to create things the body needs - such as proteins or RNA.
Dual Designations Affirm Significant Unmet Need; Multi-Year Phase 1 Data Published in the New England Journal of Medicine Underpin Advancement to Phase 2 ATLANTA, April 29, 2026 /PRNewswire/ -- ...
A case study offers insights into improving protein yield with less optimization effort and fewer processing steps ...
Cells show a remarkable resilience that allows them to thrive under different external conditions and to survive harsh situations. Gene regulation has a central role in cellular adaptation to both ...
Capitalize on biologics demand with mammalian and AI-optimized expression platforms, recurring-use products, and Asia Pacific CRO/CDMO partnerships.Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Protein ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results